Biocon Ltd.

Supreme Court's free testing order may hinder virus fight, warn business leaders

General

09 April, 2020

Supreme Court's free testing order may hinder virus fight, warn business leaders

A decision by the Supreme Court of India to make testing for coronavirus free places an unfair financial burden on ......

Healthcare

06 January, 2020

True North to invest $75 mn in Biocon's biosimilar unit

Indian biotechnology firm Biocon Ltd on Monday said that private equity firm True North will invest Rs 536.25 crore ($74.84 ......

Healthcare

03 December, 2019

Biocon elevates finance chief Siddharth Mittal as CEO

Biocon Ltd said on Tuesday it has appointed Siddharth Mittal as chief executive officer and joint managing director, in another...

Healthcare

24 September, 2019

Biocon buys Pfizer's R&D facility to boost biosimilars development

Indian biotechnology firm Biocon Ltd on Tuesday said it has acquired a Chennai-based research and development (R&D) facility...

General

21 August, 2019

Grapevine: Temasek, TrueNorth, CPPIB eye Biocon unit stake; PayU may buy PaySense

Singapore state investor Temasek, private equity firm TrueNorth, and Canadian Pension Plan Investment Board (CPPIB) are in separate...

Premium

Healthcare

18 May, 2017

True North makes partial exit from drug research firm with strong gains

Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains ......

General

22 February, 2016

Budget needs to give a push to healthcare agenda

A healthy workforce is critical for Prime Minister Narendra Modi’s ‘Make in India’ mantra to rev up India’s economic growth. ......

Healthcare

11 August, 2015

IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain

Syngene International Ltd, the research and development subsidiary of Indian biopharmaceutical major Biocon Ltd, made a strong debut on the ......

Healthcare

17 July, 2015

Biocon to open IPO of R&D arm Syngene end of this month, fixes price band

Biopharmaceutical major Biocon Ltd has fixed the price band for the initial public offering (IPO) of its research and development ......

Healthcare

23 April, 2015

Biocon to sell 10% stake in IVFA-backed R&D arm Syngene through offer-for-sale

Biopharmaceutical major Biocon Ltd's research and development arm Syngene International Ltd has filed draft red herring prospectus (DRHP) with securities ......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News